Intervention to Reduce Dietary Sodium in Hemodialysis

Completed · Not applicable

Conditions studied: Renal Dialysis

In brief

The purpose of this study is to test, in a randomized clinical trial of 200 hemodialysis patients, a behavioral intervention to reduce dietary sodium intake. The investigators will assess the impact on weight gain between dialysis treatments, blood pressures, symptoms, and health-related quality of life. The primary study hypotheses are that participants will gain less weight in between dialysis treatments, and that dietary recalls will demonstrate reduced consumption of dietary sodium.

Key facts

Study ID

NCT01125202

Run by

University of Pittsburgh

People needed

179

Starts

2009-09-01

Expected to finish

2012-09-01

Last updated by the study team

2017-08-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Individuals with end stage renal disease (ESRD) who are 18 years of age or older,
• Individuals who are literate,
• Community-dwelling adults who have been receiving maintenance dialysis for at least 3 months.

You may not qualify if…

• Individuals who cannot read or write,
• Individuals who do not speak English,
• Individuals who plan to move out of the area or change dialysis centers within the next 6 months,
• Individuals who have a life expectancy of less than 12 months,
• Individuals who are scheduled for a living donor transplant,
• Individuals who cannot see the PDA screen or use the stylus to make food selections from the PDA screen, or
• Individuals who live in an institutional setting in which they would have limited control over their dietary intake.

Where it is running

• University of Pittsburgh School of Medicine — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.